News
The acquisition expands Lilly’s pain pipeline with a slate of drugs targeting ion channel proteins like NaV1.7 and NaV1.8.
German Bionic claims Exia is the world’s first exoskeleton powered by augmented AI, a type of artificial intelligence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback